Skip to content
OpenCapital
Get started

Insight Molecular Diagnostics Inc. IMDX Q2 2025 earnings

Reported August 11, 2025 · After market close

Revenue$518.0KBeat by $218.0KDiluted EPS-$0.30Miss by $0.07
Revenue estimate$300.0K
EPS estimate-$0.23

Next report

Aug 10, 2026 (In 4 weeks)
Revenue estimate$437.5K
EPS estimate-$0.24

Financials

Q2 2025

Income statement

See full
Revenue$518.0K+398%
Gross profit$350.0K+386%
Operating income-$9.8M-112%
Net income-$9.7M-115%
EPS (diluted)-$0.30+16.7%

Balance sheet

See full
Cash & equivalents$24.3M+162%
Total debt$3.2M-9.4%
Total equity$1.1M-95.2%
Total assets$50.5M-32.4%

Cash flow

See full
Operating cash flow-$6.3M-5.4%
CapEx$349.0K+82.7%
Free cash flow-$6.6M-7.7%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$98.67M—
Enterprise value$77.58M—
P/S23.2×—

Profitability

See full
Gross margin55.5%—
Operating margin-1,498.3%-551pp
Net margin-1,489.7%-546pp
FCF margin-563.2%—

Returns & leverage

See full
Return on equity-532.9%-717pp
Debt / equity2.9×+2.8×
Current ratio4×+2.7×

Versus estimates

Revenue

Q1 2026$32.0KMiss by $197.2KQ4 2025$1.1MBeat by $854.0KQ3 2025$260.0KMiss by $25.0K
Q2 2025$518.0KBeat by $218.0K
Q1 2025$2.1MBeat by $2.0MQ4 2024$1.5MBeat by $1.3M

Diluted EPS

Q1 2026-$0.28Miss by $0.02Q4 2025-$0.27Miss by $0.03Q3 2025-$0.34Miss by $0.10
Q2 2025-$0.30Miss by $0.07
Q1 2025-$0.26Miss by $0.02Q4 2024$0.48Beat by $0.91

Ask the moment Insight Molecular Diagnostics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Insight Molecular Diagnostics Inc. report Q2 2025 earnings?
Insight Molecular Diagnostics Inc. (IMDX) reported Q2 2025 earnings on August 11, 2025 after market close.
What were Insight Molecular Diagnostics Inc.'s Q2 2025 revenue and EPS?
Insight Molecular Diagnostics Inc. reported revenue of $518.0K and diluted EPS of $-0.30 for Q2 2025.
Did Insight Molecular Diagnostics Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $300.0K by $218.0K. EPS missed the consensus estimate of $-0.23 by $0.07.
How did Insight Molecular Diagnostics Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 398.1% from $104.0K a year earlier and diluted EPS grew 16.7% from $-0.36.
Where can I find Insight Molecular Diagnostics Inc.'s Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-106552) directly on SEC EDGAR. The filing index links above go to sec.gov.